Christopher A. Kroeger
CIK 1658918 · Chief Executive Officer · last filed 2026-10-16
Christopher A. Kroeger is a Chief Executive Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $595.4K of MPLT on Oct 16, 2026. Across all open-market trades the lifetime net is −$13.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MPLT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
800 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MPLT | Chief Executive Officer | 1,297,099 | $7.66 | $9.94M | -$13.14M | 10 | 2026-10-16 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Chief Executive Officer | — | $15.90 | — | $0 | 1 | 2018-12-11 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-16 | MPLT | Sell (S) | −73,691 | -$595.4K | EDGAR |
| 2026-10-15 | MPLT | Notice (144) | −73,691 | -$575.5K | EDGAR |
| 2026-08-19 | MPLT | Grant (A) | +23,145 | $0 | EDGAR |
| 2026-07-17 | MPLT | Sell (S) | −147,639 | -$5.44M | EDGAR |
| 2026-07-15 | MPLT | Notice (144) | −152,230 | -$5.77M | EDGAR |
| 2026-05-18 | MPLT | Sell (S) | −118,235 | -$3.21M | EDGAR |
| 2026-05-11 | MPLT | Sell (S) | −68,491 | -$1.95M | EDGAR |
| 2026-05-06 | MPLT | Sell (S) | −49,744 | -$1.41M | EDGAR |
| 2026-05-04 | MPLT | Notice (144) | −236,470 | -$7.26M | EDGAR |
| 2026-04-17 | MPLT | Sell (S) | −19,187 | -$521.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.